Sensorium Therapeutics
Boston, United States· Est.
Clinical-stage biotech discovering novel CNS therapies from natural compounds validated by millennia of human use. Anxiety, epilepsy, Alzheimer's.
Private Company
Total funding raised: $60M
About
Clinical-stage biotech discovering novel CNS therapies from natural compounds validated by millennia of human use. Anxiety, epilepsy, Alzheimer's.
Psychedelics
Funding History
2Total raised:$60M
Series A$30M
Seed$30M